"10.1371_journal.pone.0137065","plos one","2015-09-09T00:00:00Z","Laura J Goodall; Milan Ovecka; Daniel Rycroft; Sarah L Friel; Andrew Sanderson; Prafull Mistry; Marie L Davies; A Allart Stoop","Biopharm Innovation Unit, Biopharm R&D, GlaxoSmithKline, Stevenage, United Kingdom; R&D Projects, Clinical Platforms and Sciences, GlaxoSmithKline, Stevenage, United Kingdom","Conceived and designed the experiments: LG MO DR AS MD AAS. Performed the experiments: LG MO DR SF AS. Analyzed the data: LG MO DR PM MD AAS. Wrote the paper: LG MO DR SF PM AS MD AAS.","The authors have read the journals policy and have the following conflicts: All authors were employees of GlaxoSmithKline at the time this work was carried out and received GSK shares as part of their remuneration. AS and AAS are named inventors on patents assigned to GlaxoSmithKline relating to TNFR1 antagonist domain antibodies (WO2010/094720, WO2011/051217 and WO2012/172070). All authors were employees of GlaxoSmithKline at the time this work was carried out. All relevant patents have been declared, and there are no products in development or marketed products to declare. This does not alter the authorsâ€™ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2015","09","Laura J Goodall","LJG",8,TRUE,6,5,6,8,TRUE,TRUE,FALSE,0,NA,FALSE
